Moflaxa (Moxifloxacin)

Moxifloxacin is a fluoroquinolone antibacterial indicated for several serious infections.

• Community-acquired pneumonia: effective treatment of bacterial pneumonia in adults.
• Acute bacterial sinusitis: resolves sinus infection caused by susceptible organisms.
• Skin and soft tissue infections: combats bacterial cellulitis and wound infections.
• Intra-abdominal infections: targets mixed aerobic and anaerobic pathogens.
• Complicated urinary tract infections: eradicates resistant uropathogens in complicated cases.

• Moxifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. By binding to these enzymes, it prevents the supercoiling and relaxation of bacterial DNA, leading to halted bacterial cell division and ultimately bacterial death. This bactericidal action is broad‑spectrum against Gram‑positive, Gram‑negative and atypical organisms.

Moxifloxacin may cause a range of adverse reactions.

Common Side Effects

• Nausea: mild to moderate upset stomach.
• Diarrhea: loose stools, sometimes watery.
• Headache: transient cranial discomfort.
• Dizziness: sensation of light‑headedness.
• Rash: mild skin erythema or pruritus.
• Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects

• Tendon rupture: especially Achilles tendon, may occur without warning.
• QT interval prolongation: risk of ventricular arrhythmias.
• Clostridioides difficile infection: severe colitis after antibiotic exposure.
• Severe allergic reactions: anaphylaxis, angioedema.
• Hepatic failure: rare but potentially life‑threatening liver injury.
• Seizures: particularly in patients with CNS disorders.

Before using Moflaxa, consider the following safety measures.

• Renal impairment: adjust dosing as per prescriber guidance.
• History of tendon disorders: avoid use due to increased rupture risk.
• QT prolongation risk: monitor ECG and avoid concomitant QT‑prolonging drugs.
• Concurrent antacids or supplements containing aluminum or magnesium: separate administration by at least 2 hours.
• Pregnancy and lactation: use only if benefits outweigh potential risks.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Moflaxa can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid)

• Other fluoroquinolones: increased risk of cumulative toxicity.
• QT‑prolonging agents (e.g., macrolides, antiarrhythmics): heightened arrhythmia risk.
• Antacids or supplements with aluminum/magnesium: markedly reduces absorption.

Moderate Interactions (Monitor Closely)

• NSAIDs: may diminish antibacterial activity.
• Corticosteroids: increased risk of tendon rupture.
• Theophylline: may raise plasma theophylline concentrations.